Last updated: February 15, 2026
Product Overview
NDC 64896-0402 corresponds to Syntocinon (oxytocin), a synthetic hormone used primarily to induce or augment labor, manage postpartum bleeding, and facilitate milk ejection. It is administered via injectable formulations, with the most common presentation being a 10 IU/mL solution.
Current Market Landscape
The global oxytocin market is driven by maternal health needs, obstetric procedures, and increasing healthcare infrastructure in emerging markets. The demand is primarily from hospitals, clinics, and obstetric practices.
Market Size Estimates
| Parameter |
2022 Data |
Projection (2027) |
Notes |
| Global oxytocin market value |
~$300 million |
~$450 million |
CAGR of 8.1% (2022-2027) [1] |
| U.S. market share |
~$125 million |
~$185 million |
Approximately 41% of global market [2] |
Market Drivers
- Rise in childbirth procedures: Increasing U-shaped and augmented deliveries globally.
- Maternal health emphasis: Policies promote labor induction to reduce maternal mortality.
- Healthcare infrastructure expansion: Particularly in Asia-Pacific and Africa.
Competitive Landscape
Major manufacturers include Ferring Pharmaceuticals, Pfizer (via partnership), and local generic producers. Patent expirations have facilitated generic entry, leading to significant price erosion.
| Company |
Product Variants |
Market Share (2022) |
Pricing Strategy |
| Ferring |
Brand (Syntocinon) |
~55% |
Premium pricing with focus on hospital procurement |
| Generics |
Multiple |
~35% |
Competitive, lower margins |
| Others |
Local brands |
~10% |
Variable |
Pricing Trends
- Brand name (Syntocinon): Price range $15–$30 per 10 mL vial in the U.S.
- Generic equivalents: Price range $5–$12 per vial.
- Cost factors: Procurement volume, hospital-negotiated discounts, and regional pricing policies.
Projected Price Trajectories (2023-2027)
| Year |
Estimated Price per Vial |
Notes |
| 2023 |
$8–$12 |
Continued generic competition pressures prices downward |
| 2024–2025 |
$7–$10 |
Further commoditization likely as more generics enter |
| 2026–2027 |
$6–$9 |
Potential stabilization, with some premium for branded versions in specific markets |
Regulatory and Policy Factors
- USFDA, EMA, and other authorities recognize oxytocin as a controlled drug with strict storage requirements.
- Price controls enacted in certain countries (e.g., India) influence local market prices.
- Patent expirations in multiple jurisdictions facilitate cheaper generic entry and price reductions.
Market Challenges
- Supply chain issues: Cold chain requirements and stability concerns.
- Regulatory hurdles: Variations between countries affect market access.
- Pricing pressures: In both developed and emerging markets, leading to squeezed margins for manufacturers.
Key Takeaways
- The global oxytocin market is expected to grow at around 8% annually, driven by obstetric procedures and expanding healthcare infrastructure.
- Prices have trended downward due to generic competition, with current U.S. prices for vials in the $8–$12 range.
- Future price reductions are likely to continue unless supply chain stability, regulatory incentives, or innovative formulations alter the landscape.
- The market remains sensitive to regional policies, especially in countries with price controls or import restrictions.
- Major players focus on hospital procurement contracts, with entry barriers for new entrants due to regulatory complexities.
FAQs
1. What are the main clinical uses of NDC 64896-0402?
It is used to induce labour, manage postpartum hemorrhage, and facilitate milk ejection during lactation.
2. How does generic competition influence the pricing of oxytocin?
Generic manufacturers typically offer lower prices, leading to a decline in overall market prices and increased accessibility.
3. What factors could slow down price reductions for oxytocin?
Supply chain constraints, regulatory hurdles, and manufacturing costs can stabilize or increase prices despite competition.
4. Are there new or alternative formulations expected in the near future?
Research into stable, heat-resistant formulations and longer-acting variants is ongoing but not yet commercially widespread.
5. How does global demand differ between developed and developing countries?
Developing countries show higher growth rates due to expanding healthcare access and higher birth rates; developed countries display relatively stable demand with emphasis on quality and safety standards.
Citations
- MarketWatch. "Oxytocin Market Size, Share & Trends Analysis Report." 2022.
- IQVIA. "Pharmaceutical Market Overview." 2022.
